Skip to Content Facebook Feature Image

Medeologix Expands Hydrophilic Coating Services, Partners with Biocoat® Incorporated to Solidify Position as The Bay Area's Premier Catheter Solutions Provider

Business

Medeologix Expands Hydrophilic Coating Services, Partners with Biocoat® Incorporated to Solidify Position as The Bay Area's Premier Catheter Solutions Provider
Business

Business

Medeologix Expands Hydrophilic Coating Services, Partners with Biocoat® Incorporated to Solidify Position as The Bay Area's Premier Catheter Solutions Provider

2024-11-06 00:00 Last Updated At:00:15

SAN JOSE, Calif., Nov. 6, 2024 /PRNewswire/ -- Medeologix, a leading brand in medical device manufacturing, today announced a significant expansion of its end-to-end catheter solutions with the addition of hydrophilic coating services, further cementing its status as the Bay Area's premier choice for advanced catheter solutions. This expansion is bolstered by a partnership with Biocoat, an industry-leading hydrophilic coating materials provider with established FDA master files to streamline regulatory approvals. This also demonstrates Medeologix's commitment to delivering premium, innovative coating solutions for cutting-edge catheter technologies.

For over two decades, Medeologix has had the privilege of growing alongside its clients, offering one-stop shop service from concept to mass production for the medical device industry. The solutions include in-house extrusion, medical balloon forming, complex catheter manufacturing, PET heat shrink tubing, over-molding, secondary operations, and finished device solutions. The expansion of hydrophilic coating services reinforces Medeologix's commitment to providing a comprehensive, one-stop shop for catheter development and manufacturing. The company's unique advantage lies in its vertically integrated approach, incorporating hydrophilic coating directly into the catheter processing workflow. This integrated service model is designed to enhance efficiency, quality, and cost-effectiveness for their clients.

"Our partnership with Biocoat is a game-changer," said Albert Weng, Chief Development Officer of Medeologix. "It allows us to offer our clients not just speed and efficiency, but also the assurance of working with industry-leading coating materials backed by robust regulatory support."

"By integrating hydrophilic coating services into our existing catheter production line, we deliver lightning-fast solutions with unprecedented efficiency," said Albert Weng. "This advancement allows us to offer our clients in the Bay Area and beyond an unparalleled combination of speed and consistency."

Key benefits of Medeologix's expanded services include:

As the Bay Area's first choice for hydrophilic coatings, Medeologix continues to set the standard for catheter manufacturing excellence. This service enhancement represents a significant step forward in the company's mission to accelerate medical device development and manufacturing.

For more information about its expanded hydrophilic coating services, please visit https://www.medeologix.com/en/service/page/hydrophilic_coating.

About Medeologix
Medeologix (www.Medeologix.com) is a global provider of medical device development and manufacturing services, collaborating with customers to deliver life-saving minimally invasive devices. The One-Stop Shop Service is supported by clinical application know-how, technical expertise, manufacturing solutions, and a relentless focus on customer and operational excellence. Medeologix streamlines the path to market, ensuring faster market penetration and driving client business success. For more information about our services, please visit Medeologix.com or send the inquiries to info@medeologix.com.

About Biocoat Incorporated 
Biocoat Incorporated is a full-service coatings provider specializing in supplying lubricious hydrophilic coatings custom engineered to meet specific clinical parameters for medical devices to original equipment manufacturers, start-up companies, and contract manufacturers. Biocoat also provides coating services and polymer services to companies requiring assistance with medical device manufacturing. To learn more about Biocoat, visit www.biocoat.com.

*Biocoat is a registered trademark of Biocoat Incorporated.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Medeologix Expands Hydrophilic Coating Services, Partners with Biocoat® Incorporated to Solidify Position as The Bay Area's Premier Catheter Solutions Provider

Medeologix Expands Hydrophilic Coating Services, Partners with Biocoat® Incorporated to Solidify Position as The Bay Area's Premier Catheter Solutions Provider

Next Article

AIMA Technology Welcomes Top U.S. Dealers to Shape the Future Together

2024-12-24 11:05 Last Updated At:11:25

TIANJIN, China, Dec. 24, 2024 /PRNewswire/ -- On December 7, 2024, AIMA Technology Group warmly invited a delegation of five top-performing U.S. IBD dealers to visit its headquarters. Accompanying the group was Angela Zheng, CEO of AIMA's U.S. subsidiary, AIMA EBIKE, along with her sales, marketing, and customer service teams. This visit not only marked a deepened connection between AIMA and the mainstream U.S. market but also provided U.S. dealers with a valuable opportunity to witness AIMA Technology's globally leading capabilities in research, development, and manufacturing of electric mobility solutions.

The delegation first toured AIMA's state-of-the-art factory in Tianjin. Aima Technology possesses production factories with extremely high levels of intelligent manufacturing Additionally, AIMA has integrated advanced technologies such as AI visual recognition and established a CNAS-certified R&D laboratory, maintaining its industry leadership in intelligent transformation. During the tour, the dealers were deeply impressed by AIMA's cutting-edge technology, large-scale production capabilities, and relentless pursuit of excellence in product development and manufacturing. They expressed that this rare visit not only enhanced their understanding of AIMA but also strengthened their confidence in promoting AIMA products as a symbol of outstanding performance and exceptional quality to their customers.

Furthermore, AIMA Technology's R&D team engaged in in-depth discussions with the dealers regarding the new models AIMA EBIKE plans to launch in 2025. The dealers test-rode prototypes of the latest models and shared their innovative insights. They expressed high praise for AIMA's product innovation capabilities and market acumen, recognizing these as key factors that distinguish AIMA in the industry.

Later, the dealers joined AIMA Technology's team to witness the rollout of the 10,000th AIMA E-Bike. This milestone moment showcased AIMA's exceptional manufacturing strength and market influence. The dealers were inspired and expressed strong confidence in the promising future of their partnership with AIMA.

This visit from the top-tier U.S. dealer delegation not only deepened mutual trust and friendship but also injected new momentum into AIMA's ambition to become a leader in the U.S. E-Bike industry by focusing on the IBD channel. Looking ahead, AIMA Technology will continue to strive to provide market-leading performance and quality, enhancing its product development and manufacturing capabilities while working hand-in-hand with global dealers to create an even brighter future.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

AIMA Technology Welcomes Top U.S. Dealers to Shape the Future Together

AIMA Technology Welcomes Top U.S. Dealers to Shape the Future Together

AIMA Technology Welcomes Top U.S. Dealers to Shape the Future Together

AIMA Technology Welcomes Top U.S. Dealers to Shape the Future Together

Recommended Articles